Literature DB >> 21879420

Improved lymph node harvest from resected colon cancer specimens did not cause upstaging from TNM stage II to III.

Kristian Storli1, Karl Søndenaa, Bjørg Furnes, Sabine Leh, Idunn Nesvik, Tore Bru, Einar Gudlaugsson, Ida Bukholm, Solveig Norheim-Andersen, Geir Eide.   

Abstract

BACKGROUND: The number of lymph nodes retrieved and examined from a resected colon cancer specimen may be crucial for correct staging. We examined if efforts to increase the lymph node harvest to more than 12 lymph nodes per specimen would upstage some patients from TNM stage II to III.
METHODS: Three hospitals compared results from 2000 with those of 2007 in 421 resected patients with stage II and III colon cancer. Hospital A endeavored to improve the surgical procedure while the pathologists enhanced the quality of lymph node sampling. Hospital B did not make any marked changes, while hospital C introduced the GEWF lymph node solvent (glacial acetic acid, ethanol, distilled water, and formaldehyde) in their pathology method.
RESULTS: In 2000, 12 or more lymph nodes were harvested in 39.6, 45.0, and 21.1% of the specimens from the three hospitals, while the figures for 2007 were 85.7, 42.0, and 90.3%, respectively. The significant increase in lymph node harvest in two of the hospitals in 2007 compared to 2000 (p < 0.001) did not affect the share of patients with stage III in 2007 (38.7%) compared to 2000 (44.1%) (p = 0.260). The number of positive lymph nodes and the lymph node ratio (LNR) decreased from 2000 to 2007. A lymph node yield of 12 or more was not associated with an increased probability of positive lymph nodes in a multivariable logistic regression analysis.
CONCLUSION: More radical surgery and dedicated pathologists and the use of the GEWF solvent significantly increased the lymph node yield but did not upstage patients from TNM stage II to III.

Entities:  

Mesh:

Year:  2011        PMID: 21879420     DOI: 10.1007/s00268-011-1248-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  28 in total

1.  An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data.

Authors:  Nancy N Baxter; Rocco Ricciardi; Marko Simunovic; David R Urbach; Beth A Virnig
Journal:  Dis Colon Rectum       Date:  2010-01       Impact factor: 4.585

2.  The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.

Authors:  Robert Rosenberg; Jutta Engel; Christiane Bruns; Wolfgang Heitland; Nikolaus Hermes; Karl-Walter Jauch; Reinhard Kopp; Eberhard Pütterich; Reinhard Ruppert; Tibor Schuster; Helmut Friess; Dieter Hölzel
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

3.  Lymph node harvest in colon cancer specimens depends on tumour factors, patients and doctors, but foremost on specimen handling.

Authors:  Kristian Storli; Christian Fredrik Lindboe; Camilla Kristoffersen; Karina Kleiven; Karl Søndenaa
Journal:  APMIS       Date:  2010-12-01       Impact factor: 3.205

4.  Skip metastases in colon cancer: assessment by lymph node mapping using molecular detection.

Authors:  A E Merrie; L V Phillips; K Yun; J L McCall
Journal:  Surgery       Date:  2001-06       Impact factor: 3.982

5.  A predictive model for lymph node yield in colon cancer resection specimens.

Authors:  Garrett M Nash; David Row; Alexander Weiss; Jinru Shia; Jose G Guillem; Philip B Paty; Mithat Gonen; Martin R Weiser; Larissa K Temple; Garrett Fitzmaurice; W Douglas Wong
Journal:  Ann Surg       Date:  2011-02       Impact factor: 12.969

6.  Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study.

Authors:  Luke Bui; Eddy Rempel; Dana Reeson; Marko Simunovic
Journal:  J Surg Oncol       Date:  2006-05-01       Impact factor: 3.454

7.  Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands.

Authors:  Wendy Kelder; Bas Inberg; Michael Schaapveld; Arend Karrenbeld; Joris Grond; Theo Wiggers; John T Plukker
Journal:  Dis Colon Rectum       Date:  2009-02       Impact factor: 4.585

8.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

Review 9.  Colorectal tumour deposits in the mesorectum and pericolon; a critical review.

Authors:  I D Nagtegaal; P Quirke
Journal:  Histopathology       Date:  2007-05-26       Impact factor: 5.087

10.  Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?

Authors:  Jiping Wang; Mahmoud Kulaylat; Howard Rockette; James Hassett; Ashwani Rajput; Kelli Bullard Dunn; Merril Dayton
Journal:  Ann Surg       Date:  2009-04       Impact factor: 12.969

View more
  12 in total

1.  More is not always better.

Authors:  Luis A Carriquiry
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 2.  A nodal positivity constant: new perspectives in lymph node evaluation and colorectal cancer.

Authors:  Niamh M Hogan; Desmond C Winter
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

3.  Extended lymphadenectomy in colon cancer is debatable.

Authors:  Jamie Murphy; Tonia Young-Fadok
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

4.  Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II.

Authors:  K E Storli; K Søndenaa; B Furnes; I Nesvik; E Gudlaugsson; I Bukholm; G E Eide
Journal:  Tech Coloproctol       Date:  2013-12-20       Impact factor: 3.781

5.  Harvest of lymph nodes in colorectal cancer depends on demographic and clinical characteristics of the patients.

Authors:  Shu-Kay Ng; Cu-Tai Lu; Sahar Pakneshan; Melissa Leung; Simon Siu; Alfred King-Yin Lam
Journal:  Int J Colorectal Dis       Date:  2017-11-13       Impact factor: 2.571

Review 6.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients.

Authors:  Yen-Jung Lu; Pei-Ching Lin; Chun-Chi Lin; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Yuan-Tzu Lan; Tzu-Chen Lin; Wen-Yi Liang; Wei-Shone Chen; Jen-Kou Lin; Shih-Ching Chang
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

Review 8.  Stage migration vs immunology: The lymph node count story in colon cancer.

Authors:  Bruno Märkl
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

9.  Short- and long-term outcomes for patients with splenic flexure tumours treated by left versus extended right colectomy are comparable: a retrospective analysis.

Authors:  Manfred Odermatt; Najaf Siddiqi; Rose Johns; Danilo Miskovic; Omar Khan; Jim Khan; Amjad Parvaiz
Journal:  Surg Today       Date:  2013-12-04       Impact factor: 2.549

10.  Increased lymph node yield in colorectal cancer is not necessarily associated with a greater number of lymph node positive cancers.

Authors:  Aisling O'Shea; Omar Aly; Craig N Parnaby; Malcolm A Loudon; Leslie M Samuel; Graeme I Murray
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.